Drawing for CELLIGENICS

USPTO serial 79268611

CELLIGENICS

Reviewed by CopyMark Law Group

Reg. 6144209Status 700Renewal
Filing date
Status date
Registration date
Sep 8, 2020
Examiner
MORRIS, KRISTINA KLOIBER
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CELLIGENICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David J. Byer

David J. Byer K&L Gates LLPOne Lincoln StreetBoston, MA 02111UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Scientific and technological services and research and design relating thereto, namely, scientific research for product development in stem cell biology, stem cells and their derivatives, stem cell commercialization methods, ancillary techniques and cell manufacturing services; industrial analysis, namely, quality and performance profiling of stem cells and their derivatives for standards development, comparison to standards and industrial research services in the field of cell and molecular biology, stem cells and their derivatives, research and analysis for standards development and quality control; stem cell research; stem cell research services; medical research services; biological research services; pharmaceutical research services; scientific research services; medical laboratory services; biochemistry research services; scientific research and industrial research services in the field of stem cell biology for clinical, cosmeceutical and biotech applications; pharmaceutical research and development services; scientific research for medical purposes; scientific laboratory services; provision of information relating to scientific research; provision of information relating to technological research in the field of stem cell biology, stem cells and their derivatives, molecular and cell biology, immunology, cancer biology and methods of use of stem cells and their derivatives in clinical, cosmeceutical and biotech applicationsACTIVE—
044Medical services; personal hygienic and beauty care for human beings; medical services relating to the removal, treatment and processing of stem cells; medical advisory services; medical analysis services for diagnostics and treatment purposes provided by medical laboratories; medical assistance services; medical care services; medical diagnostic services; medical information services; medical and healthcare services; medical testing for diagnostic or treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 8, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 12, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 23, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 31, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 30, 2020FIMPFINAL DISPOSITION PROCESSED—
Dec 8, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 8, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 23, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 23, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 19, 2020GPNXNOTIFICATION PROCESSED BY IB—
Jun 3, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 3, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 3, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 19, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 19, 2020XAECEXAMINER'S AMENDMENT ENTERED—
May 19, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 19, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
May 19, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
May 1, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 1, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 1, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 22, 2019RFNTREFUSAL PROCESSED BY IB—
Nov 1, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 1, 2019RFRRREFUSAL PROCESSED BY MPU—
Oct 12, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 11, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 8, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 4, 2019DOCKASSIGNED TO EXAMINER—
Oct 4, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 3, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance